Standout Papers

NRG Oncology/RTOG1205: A Randomized Phase II Trial of Concurrent Bevacizumab and Reirradiation Versus Bevacizumab Alone a... 2022 2026 2023 202496
  1. NRG Oncology/RTOG1205: A Randomized Phase II Trial of Concurrent Bevacizumab and Reirradiation Versus Bevacizumab Alone as Treatment for Recurrent Glioblastoma (2022)
    Christina Tsien, Stephanie L. Pugh et al. Journal of Clinical Oncology

Immediate Impact

1 by Nobel laureates 26 from Science/Nature 67 standout
Sub-graph 1 of 21

Citing Papers

Glioblastoma and Other Primary Brain Malignancies in Adults
2023 Standout
Primary brain tumours in adults
2023 Standout
10 intermediate papers

Works of Jeffrey J. Raizer being referenced

NRG Oncology/RTOG1205: A Randomized Phase II Trial of Concurrent Bevacizumab and Reirradiation Versus Bevacizumab Alone as Treatment for Recurrent Glioblastoma
2022 Standout
Historical benchmarks for medical therapy trials in surgery- and radiation-refractory meningioma: a RANO review
2014
and 8 more

Author Peers

Author Last Decade Papers Cites
Jeffrey J. Raizer 3172 1893 1454 1573 172 6.0k
Patrick Roth 3140 1038 1820 1254 197 6.9k
Philippe Métellus 2168 1730 976 1241 167 5.2k
M. Brada 3721 1940 1058 1183 121 6.6k
Jan Drappatz 2961 1142 1074 1103 154 5.2k
Uri Tabori 3115 1086 1056 2336 216 6.4k
Lakshmi Nayak 2758 2050 1752 1216 126 5.3k
John L. Villano 2532 1206 799 1007 141 4.9k
Fábio M. Iwamoto 2905 1204 683 1314 148 4.5k
Didier Frappaz 4479 2066 1039 2655 270 8.0k
C Kalifa 3085 2073 1048 2293 167 6.6k

All Works

Loading papers...

Rankless by CCL
2026